How we report
We cover the mental health industry as a business and policy beat. Reporting starts from primary documents — regulatory filings, trial registrations, company disclosures, court records, and peer-reviewed literature — and is built out through interviews with people who have direct knowledge of what we are writing about.
We prefer on-the-record sources and name them whenever we can. When a source speaks on background, we agree in advance on how they may be characterized, and we hold to it. A claim is treated as confirmed when we have documentary evidence or two independent, knowledgeable sources; a single anonymous account is reported as such, with its limits stated plainly. We give companies and individuals a fair opportunity to respond to specific findings before publication.
Reporting and opinion are kept separate. News articles establish what happened and what the evidence shows; opinion is the editor's argument about what it means, and it carries an Opinion label wherever it appears. Numbers — trial readouts, market sizes, prescription counts — are traced to their source and presented with the context that makes them meaningful rather than merely large.
How the regulatory tracker works
The regulatory tracker aggregates filings relevant to mental health from official, free government sources: the Federal Register API (FDA, DEA, CMS, SAMHSA, and NIH rules and notices), SEC EDGAR (material filings for the companies we follow), and ClinicalTrials.gov (newly posted studies in the conditions we cover). Daily runs pull the last 30 days; the historical archive was hydrated once with a 24-month backfill.
We filter for relevance using a fixed keyword set covering psychiatric indications, controlled substances, cannabinoids, behavioral health, and the companies in our coverage universe. The filter decides what surfaces; an editor decides what is worth your attention. We add short plain-language summaries and tag each item by vertical. We do not alter the underlying filings, and every item links back to the original source so you can read it yourself.
How the markets data works
Market data covers a tracked universe of public companies across pharma psychiatry, psychedelics, cannabis, and digital and behavioral health. Quotes are sourced from a third-party market data provider and refreshed on a regular schedule during U.S. market hours; prices may be delayed.
The ticker universe is selected editorially: a company earns a place because its business is materially tied to mental health treatment, not because of its size or share price. We add and remove tickers as the industry changes, and the full list — grouped by vertical — is visible on the Markets page. Index and ETF entries are included where they offer a useful read on a whole vertical. The ticker tape and movers tables read from the same list, so what you see on the front page and what you see on the Markets page never drift apart.
Corrections
We correct errors promptly and visibly. When we change the substance of a published article, we mark it as updated and note what changed. Factual corrections are labeled as corrections rather than quietly edited away, and we do not silently delete published work. If you believe something we have published is wrong, tell us — accuracy is the point of the enterprise, and a correction is a feature of doing this seriously, not an embarrassment to be hidden.